title: Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.
abstract: Over the last five years, the number of clinical trials involving AAV (adeno-associated virus) and lentiviral vectors continue to increase by about 150 trials each year. For continued success, AAV and lentiviral expression cassettes need to be designed to meet each disease's specific needs. This review discusses how viral vector expression cassettes can be engineered with elements to enhance target specificity and increase transgene expression. The key differences relating to target specificity between ubiquitous and tissue-specific promoters are discussed, as well as how endogenous miRNAs and their target sequences have been used to restrict transgene expression. Specifically, relevant studies indicating how cis-acting elements such as introns, WPRE, polyadenylation signals, and the CMV enhancer are highlighted to show their utility for enhancing transgene expression in gene therapy applications. All discussion bears in mind that expression cassettes have space constraints. In conclusion, this review can serve as a menu of vector genome design elements and their cost in terms of space to thoughtfully engineer viral vectors for gene therapy.
authors: Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
authors: Sara Kathleen
authors: SK
authors: Powell
authors: Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
authors: Ricardo
authors: R
authors: Rivera-Soto
authors: Gene Therapy Center and Department of Ophthalmology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
authors: Steven James
authors: SJ
authors: Gray
mesh_terms: D000229:Dependovirus / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D019076:Transgenes / Q000235:genetics*
references: Cardiovasc Res. 2006 Apr 1;70(1):70-8
references: 16448634
references: Mol Cell Biol. 1990 Apr;10(4):1805-10
references: 1690852
references: J Virol. 1994 May;68(5):3193-9
references: 8151782
references: Hum Gene Ther. 1996 Nov 10;7(17):2101-12
references: 8934224
references: Hum Gene Ther. 1997 Mar 20;8(5):575-84
references: 9095409
references: J Virol. 1998 Jun;72(6):5085-92
references: 9573279
references: Gene Ther. 2013 Sep;20(9):930-8
references: 23535898
references: J Neurosci Methods. 2010 May 30;189(1):56-64
references: 20347873
references: Gene Ther. 2008 Nov;15(22):1489-99
references: 18563184
references: Mol Ther. 2008 Jun;16(6):1081-8
references: 18414478
references: Gene Ther. 2007 Jun;14(11):872-82
references: 17361216
references: Exp Neurol. 2002 Jul;176(1):66-74
references: 12093083
references: Gene Ther. 2000 Aug;7(15):1304-11
references: 10918501
references: PLoS One. 2010;5(8):e12413
references: 20865032
references: Gene. 2012 Sep 15;506(2):289-94
references: 22820390
references: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1955-60
references: 12578975
references: Hum Gene Ther. 2011 Sep;22(9):1143-53
references: 21476867
references: Eur J Neurosci. 2000 May;12(5):1525-33
references: 10792430
references: J Virol. 1999 Apr;73(4):2886-92
references: 10074136
references: Nat Med. 2006 May;12(5):585-91
references: 16633348
references: Discov Med. 2013 Feb;15(81):111-9
references: 23449113
references: PLoS One. 2010;5(5):e10611
references: 20485554
references: PLoS One. 2014;9(8):e104805
references: 25118036
references: Genes Dev. 1990 Sep;4(9):1552-9
references: 1701407
references: J Biol Chem. 1995 Mar 10;270(10):5276-81
references: 7890639
references: Hum Gene Ther. 2012 May;23(5):460-72
references: 22260439
references: Gene Ther. 2014 Mar;21(3):242-52
references: 24285216
references: Appl Clin Genet. 2013 Oct 18;6:91-101
references: 24159262
references: Gene Ther. 2002 Jul;9(14):932-8
references: 12085241
references: J Gene Med. 2010 Feb;12(2):129-36
references: 20033928
references: Blood. 2007 Sep 1;110(5):1448-57
references: 17456723
references: Genes Dev. 1989 Jul;3(7):1019-25
references: 2570734
references: Methods Enzymol. 2012;507:229-54
references: 22365777
references: Hum Gene Ther. 2014 Feb;25(2):109-20
references: 24191919
references: Virology. 2003 Jun 20;311(1):89-95
references: 12832206
references: Nat Genet. 1999 Oct;23(2):185-8
references: 10508514
references: Brain Res. 1996 Mar 25;713(1-2):99-107
references: 8724980
references: Gene Ther. 1998 Jan;5(1):50-8
references: 9536264
references: Mol Ther. 2008 Feb;16(2):280-9
references: 18059373
references: Hum Gene Ther. 2001 Oct 10;12(15):1893-905
references: 11589831
references: Gene Ther. 2004 Apr;11(8):649-57
references: 14985790
references: Blood. 2005 Apr 1;105(7):2691-8
references: 15576475
references: Mol Ther. 2010 Mar;18(3):601-8
references: 19935780
references: Hum Gene Ther Clin Dev. 2013 Jun;24(2):77-85
references: 23786330
references: Mol Cell Biol. 1992 Dec;12(12):5386-93
references: 1333042
references: Exp Neurol. 1998 Apr;150(2):183-94
references: 9527887
references: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2952-7
references: 15703296
references: Chromosoma. 1985;92(2):124-35
references: 2988878
references: Cell. 1985 Jun;41(2):521-30
references: 2985280
references: Hum Gene Ther. 2001 Mar 20;12(5):563-73
references: 11268288
references: Hum Gene Ther. 2004 Aug;15(8):783-92
references: 15319035
references: Gene Ther. 2001 Sep;8(17):1323-32
references: 11571569
references: J Neurosci. 1994 Mar;14(3 Pt 1):1030-7
references: 8120611
references: Mol Cell Biol. 1995 Jul;15(7):3864-9
references: 7791793
references: Invest Ophthalmol Vis Sci. 2011 Apr;52(5):2775-83
references: 21310920
references: Mol Ther. 2000 Nov;2(5):458-69
references: 11082319
references: Expert Opin Biol Ther. 2013 Jul;13(7):987-1011
references: 23590247
references: Glia. 2009 Apr 15;57(6):667-79
references: 18942755
references: PLoS One. 2009;4(8):e6810
references: 19710912
references: Mol Ther. 2006 Sep;14(3):316-27
references: 16824801
references: Nat Biotechnol. 2007 Dec;25(12):1457-67
references: 18026085
references: J Gene Med. 2008 Nov;10(11):1163-75
references: 18773500
references: Nat Rev Genet. 2011 May;12(5):316-28
references: 21468099
references: Stem Cells Dev. 2007 Feb;16(1):167-76
references: 17348812
references: Gene Ther. 2009 Jul;16(7):927-32
references: 19458648
references: Gene Ther. 2001 Oct;8(20):1539-46
references: 11704814
references: Mol Cell Biol. 1991 Jun;11(6):3070-4
references: 2038318
references: Gene Ther. 2011 Dec;18(12):1104-10
references: 21525952
references: Mol Ther. 2007 Jun;15(6):1167-73
references: 17406345
references: Mol Ther. 2008 Oct;16(10):1648-56
references: 18682697
references: Hum Gene Ther. 2002 May 1;13(7):829-40
references: 11975849
references: J Cardiol. 2011 Jan;57(1):115-22
references: 20846825
references: Glia. 2008 Apr;56(5):481-93
references: 18240313
references: Hum Gene Ther. 1999 Sep 20;10(14):2295-305
references: 10515449
references: Hum Gene Ther. 2013 Apr;24(4):363-74
references: 23517535
references: Genes Dev. 2003 Feb 15;17(4):438-42
references: 12600936
references: J Gene Med. 2008 Jan;10(1):21-32
references: 18022932
references: Gene Ther. 2004 Jan;11(1):52-60
references: 14681697
references: Mol Brain. 2014;7:17
references: 24618276
references: Mol Ther. 2010 Mar;18(3):477-90
references: 20087315